Benjamin Eckert

Benjamin Eckert has a diverse work experience in the healthcare industry, with a focus on market access and pricing. Benjamin began their career at Barents Group as a Consultant in 1999, where they worked for three years before moving to Barents Group, BearingPoint as a Senior Consultant until 2005. In 2005, they joined Novartis as a Manager for two years. Benjamin then progressed within Novartis, holding roles such as Associate Director / Director, Global HE&OR from 2008 to 2011, and later as Director, Global Health Economics & Pricing from 2011 to 2013. Benjamin then joined Metamark Genetics in 2013 as Executive Director, Market Access before being promoted to Vice President, Market Access in 2015. Finally, in 2017, they joined Adaptive Biotechnologies Corp., where they initially held the position of Vice President, Market Access for five years before being promoted to their current role as Senior Vice President, Market Access.

Benjamin Eckert earned a Bachelor of Arts (BA) degree in Economics and Chemistry from Wake Forest University, which they attended from 1995 to 1999. Subsequently, they pursued a Master's degree in Health Policy and Management at Harvard University, where they studied from 2003 to 2005.